- $167.29bn
- $205.26bn
- $80.74bn
- 93
- 39
- 94
- 89
Annual income statement for Rtx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 56,587 | 64,388 | 67,074 | 68,920 | 80,738 |
Cost of Revenue | |||||
Gross Profit | 8,928 | 12,491 | 13,668 | 12,089 | 15,410 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 58,485 | 59,901 | 61,570 | 65,359 | 74,200 |
Operating Profit | -1,898 | 4,487 | 5,504 | 3,561 | 6,538 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2,353 | 5,109 | 6,117 | 3,836 | 6,194 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2,928 | 4,145 | 5,327 | 3,380 | 5,013 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -3,519 | 3,864 | 5,197 | 3,195 | 4,774 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3,519 | 3,864 | 5,197 | 3,195 | 4,774 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.367 | 4.11 | 4.91 | 5.36 | 5.47 |
Dividends per Share |